Results 191 to 200 of about 16,804 (217)

Chemokine ligand CX3CL1

AfCS-Nature Molecule Pages, 2010
Astrid Cardona, Richard Ransohoff
openaire   +1 more source

Chemokines: XCL1, XCL2 and CX3CL1

2022
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Das Chemokin CX3CL1 und sein Rezeptor CX3CR1 als therapeutische Zielstrukturen bei Atherosklerose

Nieren- und Hochdruckkrankheiten, 2021
E. Roy-Chowdhury, S. von Vietinghoff
openaire   +1 more source

Chemokine CX3C motif ligand 1 (CX3CL1; fractalkine)

Science-Business eXchange, 2011
openaire   +1 more source

Hypoxia Induction of Chemokine CX3CL1 Expression Via Increased Synthesis of CX3CL1 mRNA in Cultured Lung Endothelial Cells.

A106. ROLE OF INFLAMMATION IN PULMONARY VASCULAR REMODELING AND INJURY, 2009
J Zhang, NP Juedes, VM Narayan, KK Mubarak, JM Patel   +4 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly